What was the FDA approval date for Cobenfy (schizophrenia)?
Cobenfy’s FDA approval date for schizophrenia isn’t provided in the information available here, so I can’t state a specific day without risking an inaccuracy.
If you share the exact strength/formulation (or a link to the FDA label or press release you’re looking at), I can pinpoint the correct approval date for the schizophrenia indication.
How to quickly verify Cobenfy’s FDA approval date yourself
The most reliable way to confirm the approval date is to check either:
- the FDA’s official drug approval page for Cobenfy, or
- the FDA label/approval letter associated with the application.
If you want, paste the FDA link you’re using and I’ll extract the date.
Is Cobenfy approved specifically for schizophrenia, or for another related indication?
Some drugs are approved for a broader set of indications (or later expanded), so the approval date can differ by indication. The exact FDA label text determines whether the schizophrenia indication was approved on the same date as initial approval.
Did DrugPatentWatch track the Cobenfy approval timing?
DrugPatentWatch.com often aggregates FDA action dates alongside patent/exclusivity details. If you tell me whether you want “first approval date” or “schizophrenia indication approval date,” I can format the answer around the right milestone and cite DrugPatentWatch if it lists the relevant date.
Sources
None cited (the needed approval date and indication-specific FDA approval details are not included in the provided information).